Sprint Bioscience AB | Balance Sheet
Fiscal year is January-December. All values SEK Thousands.
2014
2015
2016
2017
Cash & Short Term Investments
13,976.30
7,627.20
23,606.70
1,479.00
Total Accounts Receivable
1,118.40
5,667.10
2,667.20
2,687.00
Other Current Assets
-
1,305.20
640.90
713.00
Total Current Assets
15,094.70
14,599.60
26,914.80
4,879.00
Net Property, Plant & Equipment
546.80
1,152.10
1,872.30
1,512.00
Intangible Assets
9,505.60
14,881.50
20,734.50
29,094.00
Total Assets
25,147.10
30,633.20
49,521.60
35,485.00
ST Debt & Current Portion LT Debt
769.20
769.20
769.20
-
Accounts Payable
887.90
2,583.30
3,621.00
3,394.00
Income Tax Payable
30.80
68.50
-
-
Other Current Liabilities
1,600.30
21,622.70
16,636.60
4,002.00
Total Current Liabilities
3,288.30
25,043.70
21,026.80
7,396.00
Long-Term Debt
1,538.50
769.20
-
-
Total Liabilities
4,826.80
25,813.00
21,026.80
7,396.00
Common Equity (Total)
20,320.30
4,820.20
28,494.80
28,089.00
Total Shareholders' Equity
20,320.30
4,820.20
28,494.80
28,089.00
Total Equity
20,320.30
4,820.20
28,494.80
28,089.00
Liabilities & Shareholders' Equity
25,147.10
30,633.20
49,521.60
35,485.00
About Sprint Bioscience AB
View Profile
